- Home
- WRBY vs IMCR Comparison
WRBY vs IMCR Comparison
Compare WRBY & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRBY
- IMCR
- Stock Information
- Founded
- WRBY 2010
- IMCR 2008
- Country
- WRBY United States
- IMCR United Kingdom
- Employees
- WRBY N/A
- IMCR N/A
- Industry
- WRBY Ophthalmic Goods
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WRBY Health Care
- IMCR Health Care
- Exchange
- WRBY Nasdaq
- IMCR Nasdaq
- Market Cap
- WRBY 1.9B
- IMCR 1.7B
- IPO Year
- WRBY 2021
- IMCR 2021
- Fundamental
- Price
- WRBY $17.23
- IMCR $32.85
- Analyst Decision
- WRBY Buy
- IMCR Buy
- Analyst Count
- WRBY 8
- IMCR 14
- Target Price
- WRBY $16.88
- IMCR $74.75
- AVG Volume (30 Days)
- WRBY 1.4M
- IMCR 267.8K
- Earning Date
- WRBY 11-07-2024
- IMCR 11-05-2024
- Dividend Yield
- WRBY N/A
- IMCR N/A
- EPS Growth
- WRBY N/A
- IMCR N/A
- EPS
- WRBY N/A
- IMCR N/A
- Revenue
- WRBY $719,929,000.00
- IMCR $280,914,000.00
- Revenue This Year
- WRBY $15.94
- IMCR $25.60
- Revenue Next Year
- WRBY $13.07
- IMCR $10.63
- P/E Ratio
- WRBY N/A
- IMCR N/A
- Revenue Growth
- WRBY 13.67
- IMCR 27.95
- 52 Week Low
- WRBY $9.83
- IMCR $29.72
- 52 Week High
- WRBY $18.37
- IMCR $76.98
- Technical
- Relative Strength Index (RSI)
- WRBY 57.79
- IMCR 52.76
- Support Level
- WRBY $16.71
- IMCR $31.10
- Resistance Level
- WRBY $17.86
- IMCR $35.47
- Average True Range (ATR)
- WRBY 0.66
- IMCR 1.49
- MACD
- WRBY 0.01
- IMCR 0.17
- Stochastic Oscillator
- WRBY 62.77
- IMCR 51.98
About WRBY Warby Parker Inc.
Warby Parker Inc is engaged in designing and developing designer prescription glasses and contacts, and providing the facility of eye exams and vision tests. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.